Showing results (231-240 of 248) with videos related to
Sort By:
Pageof 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2023
Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor-Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA TrialSoo Yeon Baek, Woo Chul Noh, Sei-Hyun Ahn, et al.Expert Opinion on Biological Therapy|April 26, 2024
Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance studyMin Ho Park, Jae Hong Seo, Jung Ho Park, et al.Journal of Breast Cancer|January 30, 2026
Prospective Single-Arm Study of Endocrine Therapies With Ovarian Function Suppression in Premenopausal Node-Positive Early Breast Cancer Patients With Low Genomic Risk (INTERSTELLAR Trial, KBCSG-25)Sung Gwe Ahn, Sung Hoon Sim, Taewoo Kang, et al.Nature Communications|July 8, 2020
Proton-transfer-induced 3D/2D hybrid perovskites suppress ion migration and reduce luminance overshootHobeom Kim, Joo Sung Kim, Jung-Min Heo, et al.Journal of Breast Cancer|March 3, 2024
Omission of Breast Surgery in Predicted Pathologic Complete Response after Neoadjuvant Systemic Therapy: A Multicenter, Single-Arm, Non-inferiority TrialJi-Jung Jung, Jong-Ho Cheun, Soo-Yeon Kim, et al.Molecular Neurodegeneration|October 17, 2025
Neurotherapeutic effects of Vutiglabridin as a Paraoxonase-2 modulator in preclinical models of Parkinson's diseaseHeeyoung An, Sora Kang, Jaejin Shin, et al.Human Molecular Genetics|June 30, 2016
Genome-wide association study in East Asians identifies two novel breast cancer susceptibility lociMi-Ryung Han, Jirong Long, Ji-Yeob Choi, et al.Breast (Edinburgh, Scotland)|October 6, 2023
An observational, prospective, open label, multicenter study to evaluate the safety and effectiveness of pegfilgrastim as secondary prophylaxis to decrease the incidence of febrile neutropenia in Korean female patients with breast cancerAnbok Lee, Taewoo Kang, Su Hwan Kang, et al.Frontiers in Oncology|October 20, 2025
Comparative study on bone mineral density in premenopausal patients with estrogen receptor-positive breast cancer in ASTRRA Study: a 5-year follow-up studyEunju Shin, Seung Il Kim, Min-Ho Park, et al.Frontiers in Oncology|November 24, 2025
Correction: Comparative study on bone mineral density in premenopausal patients with estrogen receptor-positive breast cancer in ASTRRA Study: a 5-year follow-up studyEunju Shin, Seung Il Kim, Min-Ho Park, et al.Pageof 25